MedTrace Logo

Gonadal Tissue Cryopreservation for Fertility Preservation in Children with a Disorder of Sex Development

NCT06692049 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2024-11-18

No results posted yet for this study

Summary

The purpose of this study is to offer gonadal tissue freezing and storage to children who are diagnosed with a disorder of sex development (DSD), who are at increased risk of infertility and certain malignancies (cancer). This study involves the storage of gonadal tissue that is being removed for medical reasons (e.g. prevention of cancer development). It includes the processing and freezing of this gonadal tissue, hopefully for potential future use. The tissue will then be stored long-term until the child wishes to try to use the tissue.

Conditions

  • DSD, 46,XY
  • DSD, Ovotesticular
  • DSD, Sex Chromosome
  • Disorders of Sex Development
  • Disorder of Sex Development, 46,XY
  • Disorder of Sex Development, 46,Xy, Cbx2-Related

Interventions

PROCEDURE

Gonadectomy

Gonadal tissue being removed for risk of malignancy may be cryopreserved for fertility preservation

Sponsors & Collaborators

  • Ann & Robert H Lurie Children's Hospital of Chicago

    collaborator OTHER

  • Erin Rowell

    lead OTHER

Principal Investigators

  • Erin Rowell, MD · Ann & Robert H Lurie Children's Hospital of Chicago

Eligibility

Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-04
Primary Completion
2030-12-31
Completion
2035-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06692049 on ClinicalTrials.gov